扩散加权成像在鼻咽癌诊断和治疗中的应用

摘要/Abstract

摘要：早期疗效的判断对鼻咽癌的治疗及患者的预后有重要意义。磁共振扩散加权成像（DWI）作为一种快速成像技术，它以表观扩散系数（ADC）定量分析组织水分子弥散程度的变化，从而准确诊断鼻咽癌微小病变、评价放疗早期疗效及观察预后。随着MRI及数据分析技术的不断完善和进步，DWI在鼻咽癌的诊断和治疗中显示出更加广阔的应用前景。

关键词:鼻咽肿瘤,磁共振成像,弥散,诊断,治疗,表观扩散系数

Abstract:The judgment of early curative effect is important to the treatment of nasopharyngeal carcinoma and the prognosis of the patients. As a rapid imaging technique, magnetic resonance diffusion weighted imaging (DWI) is used to quantitatively analyze the changes of water molecules in the tissue by means of apparent diffusion coefficient (ADC), so as to diagnose the small lesions of nasopharyngeal carcinoma accurately, evaluate the early curative effect and observe the prognosis. With the continuous improvement and progress of MRI and data analysis technology, DWI in the diagnosis and treatment of nasopharyngeal carcinoma shows a broader application prospect.

Key words:Nasopharyngeal neoplasms,Diffusion magnetic resonance imaging,Diagnosis,Therapy,Apparent diffusion coefficient

徐金鹏,任瑞美,刘希光,周静,刘志成. 扩散加权成像在鼻咽癌诊断和治疗中的应用[J]. 国际肿瘤学杂志, 2017, 44(10): 771-774.

Xu Jinpeng, Ren Ruimei, Liu Xiguang, Zhou Jing, Liu Zhicheng. Application of diffusion weighted imaging in the diagnosis and treatment of nasopharyngeal carcinoma[J]. Journal of International Oncology, 2017, 44(10): 771-774.

参考文献

［1］ Chong VH, Ong CK. Nasopharyngeal carcinoma［J］. Eur J Radiol, 2008, 66(3): 437447. DOI: 10.1016/j.ejrad.2008.03.029. ［2］ Yu X, Ren R, Liu S, et al. Application and advances of diffusionweighted imaging in diagnosis and treatment of breast cancer［J］. Zhonghua Zhong Liu Za Zhi, 2014, 36(10): 721725. ［3］ Yokota H, Sakai K, Tazoe J, et al. Clinical feasibility of simultaneous multislice imaging with blippedCAIPI for diffusionweighted imaging and diffusiontensor imaging of the brain［J］. Acta Radiol, 2017, In press. DOI: 10.1177/0284185117692171. ［4］ Mihai PG, Otto M, Domin M, et al. Brain imaging correlates of recovered swallowing after dysphagic stroke: a fMRI and DWI study［J］. Neuroimage Clin, 2016, 12(12): 10131021. DOI: 10.1016/j.nicl.2016.05.006. ［5］曹诗林, 李莹, 徐坚民, 等. 磁共振扩散加权成像在评估鼻咽癌放射治疗中的应用［J］. 实用放射学杂志, 2010, 26(6): 795796. DOI: 10.3969/j.issn.10021671.2010.06.007. ［6］ Fong D, Bhatia KS, Yeung D, et al. Diagnostic accuracy of diffusionweighted MR imaging for nasopharyngeal carcinoma, head and neck lymphoma and squamous cell carcinoma at the primary site［J］. Oral Oncol, 2010, 46(8): 603606. DOI: 10.1016/j.oraloncology.2010.05.004. ［7］ Eisenhauer EA, Therasse P, Bogaerts J, et al. New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)［J］. Eur J Cancer, 2009, 45(2): 228247. DOI: 10.1016/j.ejca.2008.10.026. ［8］龚唯, 周菊英, 吴琼, 等. MRI成像对鼻咽癌的分期、诊断及治疗优势的探讨［J］. 肿瘤防治研究, 2012, 39(4): 455459. DOI: 10.3971/j.issn.10008578.2012.04.023. ［9］ Varoquaux A, Rager O, Lovblad KO, et al. Functional imaging of head and neck squamous cell carcinoma with diffusionweighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV［J］. Eur J Nucl Med Mol Imaging, 2013, 40(6): 842852. DOI: 10.1007/s0025901323519. ［10］朱培杨, 周玮, 黄小燕, 等. MR扩散加权成像在鼻咽良恶性病变及鼻咽癌T分期中的诊断价值［J］. 中国现代医生, 2014, 52(36): 5558. ［11］ Li H, Wang DL, Liu XW, et al. MRI signal changes in the skull base bone after endoscopic nasopharyngectomy for recurrent NPC: a serial study of 9 patients［J］. Eur J Radiol, 2013, 82(2): 309315. DOI: 10.1016/j.ejrad.2012.10.022. ［12］ Yuan J, Yeung DK, Mok GS, et al. NonGaussian analysis of diffusion weighted imaging in head and neck at 3T: a pilot study in patients with nasopharyngeal carcinoma［J］. PLoS One, 2014, 9(1): 8724. DOI: 10.1371/journal.pone.0087024. ［13］ Vandecaveye V, De Keyzer F, Vander Poorten V, et al. Head and neck squamous cell carcinoma: value of diffusionweighted MR imaging for nodal staging［J］. Radiology, 2009, 251(1): 134146. DOI: 10.1148/radiol.2511080128. ［14］ Lai V, Khong PL. Updates on MR imaging and 18FFDG PET/CT imaging in nasopharyngeal carcinoma［J］. Oral Oncol, 2014, 50(6): 539548. DOI: 10.1016/j.oraloncology.2013.05.005. ［15］ Abdel Razek AA, Kamal E. Nasopharyngeal carcinoma: correlation of apparent diffusion coefficient value with prognostic parameters［J］. Radiol Med, 2013, 118(4): 534539. DOI: 10.1007/s115470120890x. ［16］ Zhang GY, Wang YJ, Liu JP, et al. Pretreatment diffusionweighted MRI can predict the response to neoadjuvant chemotherapy in patients with nasopharyngeal carcinoma［J］. Biomed Res Int, 2015, 2015: 307943. DOI: 10.1155/2015/307943. ［17］ Hong J, Yao Y, Zhang Y, et al. Value of magnetic resonance diffusionweighted imaging for the prediction of radiosensitivity in nasopharyngeal carcinoma［J］. Otolaryngol Head Neck Surg, 2013, 149(5): 707713. DOI: 10.1177/0194599813496537. ［18］ King AD, Chow KK, Yu KH, et al. Head and neck squamous cell carcinoma: diagnostic performance of diffusionweighted MR imaging for the prediction of treatment response［J］. Radiology, 2013, 266(2): 531538. DOI: 10.1148/radiol.12120167. ［19］柳善刚, 任瑞美. 弥散加权成像在肿瘤疗效监测和评估中的应用及进展［J］. 中华临床医师杂志(电子版), 2015, 9(2): 327328. DOI: 10.3877/cma.j.issn.16740785.2015.02.033. ［20］林蒙, 余小多, 罗德红, 等. MR扩散加权成像预测鼻咽癌患者同步放化疗疗效的可行性［J］. 中华放射学杂志, 2014, 48(6): 467471. DOI: 10.3760/cma.j.issn.10051201.2014.06.007. ［21］ Chen Y, Liu X, Zheng D, et al. Diffusionweighted magnetic resonance imaging for early response assessment of chemoradiotherapy in patients with nasopharyngeal carcinoma［J］. Magn Reson Imaging, 2014, 32(6): 630637. DOI: 10.1016/j.mri.2014.02.009. ［22］李伟, 彭俊琴, 卢斌贵, 等. 不同ADC值及标准差在评估鼻咽癌近期疗效中的比较［J］. 广东医学, 2016, 37(21): 32173220. DOI: 10.3969/j.issn.10019448.2016.21.020. ［23］ Ji C, Zhang Q, Guan W, et al. Role of intravoxel incoherent motion MR imaging in preoperative assessing HER2 status of gastric cancers［J］. Oncotarget, 2017, 5(2): 110. DOI: 10.18632/oncotarget.17570.

[1]	刘娜, 寇介丽, 杨枫, 刘桃桃, 李丹萍, 韩君蕊, 杨立洲.血清miR-106b-5p、miR-760联合低剂量螺旋CT诊断早期肺癌的临床价值[J]. 国际肿瘤学杂志, 2024, 51(6): 321-325.
[2]	钱晓涛, 石子宜, 胡格, 吴晓维.Ⅲ~ⅣA期食管鳞状细胞癌放化疗后行巩固化疗的疗效：一项真实世界临床研究[J]. 国际肿瘤学杂志, 2024, 51(6): 326-331.
[3]	杨蜜, 别俊, 张加勇, 邓佳秀, 唐组阁, 卢俊.局部晚期可切除食管癌新辅助治疗疗效及预后分析[J]. 国际肿瘤学杂志, 2024, 51(6): 332-337.
[4]	袁健, 黄燕华.Hp-IgG抗体联合血清DKK1、sB7-H3对早期胃癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(6): 338-343.
[5]	张百红, 岳红云.新作用机制的抗肿瘤药物进展[J]. 国际肿瘤学杂志, 2024, 51(6): 354-358.
[6]	许凤琳, 吴刚.EBV在鼻咽癌肿瘤免疫微环境和免疫治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 359-363.
[7]	王盈, 刘楠, 郭兵.抗体药物偶联物在转移性乳腺癌治疗中的研究进展[J]. 国际肿瘤学杂志, 2024, 51(6): 364-369.
[8]	张宁宁, 杨哲, 檀丽梅, 李振宁, 王迪, 魏永志.宫颈细胞DNA倍体分析联合B7-H4和PKCδ对宫颈癌的诊断价值[J]. 国际肿瘤学杂志, 2024, 51(5): 286-291.
[9]	陈琦, 徐晨阳, 王寅, 雷大鹏.高光谱成像在头颈部肿瘤诊疗中的应用现状[J]. 国际肿瘤学杂志, 2024, 51(5): 298-302.
[10]	王培鑫, 赵军, 徐世红, 姜朝阳, 王小强, 杨红娟.铁死亡相关机制在骨肉瘤中的应用进展[J]. 国际肿瘤学杂志, 2024, 51(5): 308-311.
[11]	王昆, 周中新, 臧其威.血清TGF-β1、VEGF水平对非小细胞肺癌患者单孔胸腔镜根治术后复发的预测价值[J]. 国际肿瘤学杂志, 2024, 51(4): 198-203.
[12]	萨蔷, 徐航程, 王佳玉.乳腺癌免疫治疗研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 227-234.
[13]	杨智, 陆以乔, 顾花艳, 丁佳玲, 郭贵龙.肿瘤微环境介导乳腺癌靶向治疗耐药的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 235-238.
[14]	王子豪, 王宇, 杨鑫, 何艺, 莫兴奎, 袁涛.铁死亡在骨肉瘤中的分子机制及相关治疗的研究进展[J]. 国际肿瘤学杂志, 2024, 51(4): 239-244.
[15]	张栋岩, 王品, 魏秋亚, 邓成伍, 魏相相, 高远飞, 王琛.索凡替尼靶向联合卡培他滨和奥沙利铂治疗肝内胆管癌术后患者1例及文献复习[J]. 国际肿瘤学杂志, 2024, 51(4): 249-253.